Author Archives: Peter Megdal PhD

01
Feb
Date February 1, 2026
Author Peter Megdal PhD

Physiological Optimization and Lifespan Performance Modeling in Elite Masters Cycling

What Peter Megdal’s World Hour Record Reveals About Aging, Fitness, and Cardiovascular Recovery

For decades, human athletic performance was assumed to follow a largely linear decline beginning in early adulthood. Conventional physiological models predicted that the cardiovascular system, pulmonary capacity, and skeletal muscle function would steadily deteriorate as cellular senescence accumulated.
Read More
Author Peter Megdal PhD
30
Jan
Date January 30, 2026
Author Peter Megdal PhD

A New Way of Looking Inside Your Heart Without Surgery – The Best Way to Predict a Heart Attack

The Bergström Study and the Paradigm Shift in Primary Prevention

The publication of the Bergström et al. study in the Journal of the American Medical Association (JAMA) on November 9, 2025, represents a landmark moment in the transition from population-based risk estimation to individualized, disease-based risk assessment.¹ This observational cohort study, conducted as part of the Swedish Cardiopulmonary Bioimage Study (SCAPIS), analyzed 24,791 individuals aged 50 to 64 years without established cardiovascular disease.
Read More
Author Peter Megdal PhD
28
Jan
Date January 28, 2026
Author Peter Megdal PhD

Heart Disease and Fish Oil

Heart Disease and The Fish-Oil Confusion, the Vascepa Controversy, and What the Evidence Actually Shows

For decades, cardiovascular medicine has been dominated by a single, often misunderstood narrative: “Fish oil is good for your heart.” This belief has become so culturally entrenched that it blurs the line between evidence-based cardiology and retail wellness, leading millions of people to consume omega-3 supplements daily in the hope of reducing cardiovascular risk.
Read More
Author Peter Megdal PhD
19
Jan
Date January 19, 2026
Author Peter Megdal PhD

LDL “BAD” Cholesterol: Apolipoprotein B, Imaging Resolution, and the Illusion of “Normal” Coronary Arteries at Age 60

Apolipoprotein B, Imaging Resolution, and the Illusion of “Normal” Coronary Arteries at Age 60. The clinical assertion that individuals maintaining markedly elevated levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB) can possess anatomically “normal” coronary arteries at age 60 represents a diagnostic paradox.
Read More
Author Peter Megdal PhD
19
Jan
Date January 19, 2026
Author Peter Megdal PhD

Cholesterol for Athletes: How to Lower LDL Without Losing Your Edge (A Practical Guide to Statins)

If you’re an endurance athlete, you’ve probably had this moment: your fitness is undeniable—resting heart rate is low, VO₂ is high, your training log looks like a work of art—and then a blood test shows LDL (“bad cholesterol”) is higher than expected.

That can feel unfair. It can also trigger a very specific fear:
“If I take a statin, will I lose performance?”
Read More
Author Peter Megdal PhD
1 … 5 6 7 8 9 … 14
© 2026 Curing Heart Disease, LLC. All rights reserved.

Curing Heart Disease, LLC is a registered business name and does not imply the diagnosis, treatment, cure, or prevention of any disease. Information is educational only and not medical advice.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Receive the latest news

Subscribe To Our Newsletter

Get notified about new articles.